Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • luc
    Senior Member
    • Dec 2010
    • 469

    #1

    drop the Hiseqs - get an X10 instead

    In a new episode of Illumina's arbitrary gaming of the sequencing market fight for scientific progress, it opens the X10s and X5s for the resequencing of all genomes:


    Theoretically, this leaves RNA-seq for the Hiseqs.
  • AllSeq
    Registered Vendor
    • Oct 2013
    • 138

    #2
    Originally posted by luc View Post
    In a new episode of Illumina's arbitrary gaming of the sequencing market fight for scientific progress, it opens the X10s and X5s for the resequencing of all genomes:


    Theoretically, this leaves RNA-seq for the Hiseqs.
    Not quite. Illumina is still (arbitrarily) limiting the HiSeq X to "large" genomes. They're trying to encourage (accommodate) large projects sequencing crop species, livestock, model mammalian species, etc. Smaller genomes need not apply.
    AllSeq - The Sequencing Marketplace
    [email protected]
    www.AllSeq.com

    Comment

    • luc
      Senior Member
      • Dec 2010
      • 469

      #3
      The press release says:
      " ... will allow for market expansion and population-scale sequencing of non-human species in a variety of markets, including plants and livestock in agricultural research and model organisms in pharmaceutical research. Previously, it has been cost prohibitive to sequence non-human genomes at high coverage. ..."
      This can be anything as far as I can see. Illumina is not going to check on what is being sequenced anyhow.

      Comment

      • AllSeq
        Registered Vendor
        • Oct 2013
        • 138

        #4
        I can't say what Illumina will and won't check, but based on what info we've been able to gather (customer conversations, analyst questions), Illumina definitely intends this to be for large genomes only. That said, I'm not sure how useful such a large platform would be for small genomes - it would take a LOT of samples to fill out a run. But maybe there are ultra-large small genome projects just waiting for this opportunity.
        AllSeq - The Sequencing Marketplace
        [email protected]
        www.AllSeq.com

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #5
          @AllSeq: Analysis of HiSeq X data happens on the attached computer (or in BaseSpace) so this "large" genome restriction could be enforced "inline"?

          It sounds to me like they are opening HiSeq X up for large plant/animal biotech companies that previously could not use HiSeq X. They probably have tens of thousands of samples that could be multiplexed.

          Comment

          • AllSeq
            Registered Vendor
            • Oct 2013
            • 138

            #6
            @GenoMax: We don't use the instruments ourselves, so I'm not really sure about the workflow and exactly how Illumina monitors what's going on. We've heard of a couple of examples of providers 'bending the rules', but it always seems to be with the permission of Illumina. We've never heard of a full-blown 'breach of contract'. Not sure if that elicits a tap on the shoulder from the local FAS or perhaps a friendly call from Jay Flatley? ;-)

            And, yes, I think they're definitely looking to serve the PAG market. It's pretty clear from their quarterly reports (and from what we see on the Sequencing Marketplace) that there's quite a bit of excess X capacity out there. Illumina would love to fill that up (and entice new markets to purchase X's).
            AllSeq - The Sequencing Marketplace
            [email protected]
            www.AllSeq.com

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
              by SEQadmin2




              NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
              Today, 06:46 AM
            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-28-2026, 09:57 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-28-2026, 09:51 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            67 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            47 views
            0 reactions
            Last Post SEQadmin2  
            Working...